Will Value-based Care Save the Health Care System?
Couldn't join us for the event? Check out some of the panelists' slide presentations below!
Description
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
This event was free and open to the public.
CLE Credits
The following CLE credits are available to practitioners watching the recordings of this program:
-
4.0 Transitional NY Professional Practice credits
-
3.5 CA General credits
If you would like to receive CLE credit, please record the CLE code mentioned in each recording in the affirmation form available here and send it to CLE.team@ropesgray.com.
Please note that the Petrie-Flom Center is not involved in granting CLE credits for this event. All questions should be directed to Ropes & Gray at CLE.team@ropesgray.com.
Agenda
8:30 - 9:00am, Registration
9:00 - 9:15am, Welcome Remarks
-
Carmel Shachar, Executive Director, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
9:15 - 9:45am, Keynote
-
Robert S. Kaplan, Senior Fellow and Marvin Bower Professor of Leadership Development Emeritus, Harvard Business School
9:45 - 10:45am, Panel Discussion: Is the Current Regulatory Framework Stifling Value-based Health Care?
-
Austin Frakt, Associate Professor, Boston University School of Public Health; Visiting Associate Professor, Harvard T. H. Chan School of Public Health
-
Karen Gledhill, Senior Vice President and General Counsel, Fresenius Medical Care North America
-
Lee Sacks, Executive Vice President and Chief Medical Officer, Advocate Health Care and Chief Executive Officer of Advocate Physician Partners
-
Moderator: Carmel Shachar, Executive Director, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
10:45 - 11:00am, Break
11:00am - 12:00pm, Panel Discussion: The Importance of Data in Value-based Health Care
-
Deborah Gersh, Partner, Ropes & Gray
-
David Peloquin, Associate, Ropes & Gray
-
Charles Safran, Professor of Medicine and Chief, Division of Clinical Informatics, Beth Israel Deaconess Medical Center
-
Moderator: David O’Brien, Senior Researcher, Berkman Klein Center for Internet and Society, Harvard University
12:00 - 1:00pm, Lunch
1:00 - 2:30pm, Panel Discussion: Innovative Business Models in the Emerging Value-based Health Care Landscape
-
Leemore Dafny, Bruce V. Rauner Professor of Business Administration, Harvard Business School
-
Thomas Lee, Chief Medical Officer, Press Ganey Associates
-
Timothy McCrystal, Partner, Ropes & Gray
-
Betsy Van Hecke, Vice President, Legal, Cardiac and Vascular Group, Medtronic
-
Moderator: Timothy Layton, Assistant Professor of Health Care Policy, Harvard Medical School
2:30 - 2:45pm, Break
2:45 - 3:45pm, Panel Discussion: Can Value-based Contracting Work for Pharma Companies?
-
Aaron S. Kesselheim, Director, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham & Women’s Hospital, and Associate Professor of Medicine, Harvard Medical School
-
Ira Klein, Senior Director of Quality, Strategic Customer Group, Janssen Pharmaceutical Companies of Johnson & Johnson
-
Rachel E. Sachs, Associate Professor of Law, Washington University St. Louis College of Law
-
Michael Sherman, Senior Vice President and Chief Medical Officer, Health Services, Harvard Pilgrim Health Care
-
Moderator: Kevin Costello, Litigation Director, Center for Health Law and Policy Innovation and Lecturer on Law, Harvard Law School
3:45 - 4:00pm, Break
4:00 - 5:00pm, Panel Discussion: What’s next? Predictions on the Future of Value-based Health Care
-
Rushika Fernandopulle, Co-Founder and CEO, Iora Health
-
Megan North, President, Value-Based Care, Conifer Health Solutions
-
Robert Parke, Principal and Consulting Actuary, Milliman
-
Meredith Rosenthal, Senior Associate Dean for Academic Affairs and Professor of Health Economics and Policy, Harvard T. H. Chan School of Public Health
-
Josh Seidman, Senior Vice President, Avalere Health
-
Moderator: Thomas W. Feeley, Senior Fellow, Harvard Business School and Professor Emeritus at the University of Texas MD Anderson Cancer Center
Learn More!
Slide Presentations
-
Deborah Gersh, "Data in Value-Based Health Care"
-
Robert S. Kaplan, "Value-Based Health Care"
-
Aaron S. Kesselheim, "Prescription Drug Prices and Value"
-
Ira Klein, "Can Value-based Contracting Work
for Pharma Companies?" -
Rachel E. Sachs, "Defining the Scope of Value-Based Pricing"
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with support from the Oswald DeN. Cammann Fund and Ropes & Gray LLP.
Videos
Video: Welcome
Video: Robert S. Kaplan, Keynote Address, Value-based Health Care
Video: Introduction,Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Thomas Bulleit, Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Austin Frakt, Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Karen Gledhill, Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Lee Sacks, Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Audience Q&A, Is the Current Regulatory Framework Stifling Value-based Health Care?
Video: Introduction, The Importance of Data in Value-based Health Care
Video: Charles Safran,The Importance of Data in Value-based Health Care
Video: Deborah Gersh, The Importance of Data in Value-based Health Care
Video: David Peloquin, The Importance of Data in Value-based Health Care
Video: Audience Q&A, The Importance of Data in Value-based Health Care
Video: Introduction, Innovative Business Models in the Emerging Value-based Health Care Landscape
Video: Audience Q&A, Innovative Business Models in the Emerging Value-based Health Care Landscape
Video: Introduction, Can Value-based Contracting Work for Pharma Companies?
Video: Aaron S. Kesselheim, Can Value-based Contracting Work for Pharma Companies?
Video: Rachel E. Sachs, Can Value-based Contracting Work for Pharma Companies?
Video: Michael Sherman, Can Value-based Contracting Work for Pharma Companies?
Video: Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Video: Introduction, What’s next? Predictions on the Future of Value-based Health Care
Video: Meredith Rosenthal, What’s next? Predictions on the Future of Value-based Health Care
Video: Josh Seidman, What’s next? Predictions on the Future of Value-based Health Care
Video: Megan North, What’s next? Predictions on the Future of Value-based Health Care
Video: Robert Parke, What’s next? Predictions on the Future of Value-based Health Care
Video: Rushika Fernandopulle, What’s next? Predictions on the Future of Value-based Health Care
Video: Audience Q&A, What’s next? Predictions on the Future of Value-based Health Care
Tags
biotechnology health care finance health law policy insurance medicare-medicaid pharmaceuticals public health regulation